How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

824 results for

Athletic Heart Syndrome

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes

tachycardia, exercise-induced heart block, hypertrophic cardiomyopathy with sustained ventricular tachycardia or multiple risk factors, dilated cardiomyopathy unrelated to an athlete’s heart, left ventricular noncompaction with left ventricular dysfunction and or ventricular arrhythmia, Marfan syndrome with aortic dilatation, significant aortic dilatation, coronary artery aneurysm with ischemia, oral anticoagulation treatment in an athlete competing in sports with a high risk of injury causing bleeding (...) Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 35, Issue 1, Pages 1–11 Canadian Cardiovascular Society/Canadian

2018 Canadian Cardiovascular Society

2. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association

Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association Circulation. 2016;134:e535–e578. DOI: 10.1161/CIR.0000000000000450 December 6, 2016 e535 CLINICAL STATEMENTS AND GUIDELINES T he comorbidities of hypertension, diabetes mellitus, obesity, hyperlipidemia, and metabolic syndrome are common in patients with heart failure (HF (...) Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; and Council on Quality and Outcomes Research Contributory risk and Management of Comorbidities of Hypertension, obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure A Scientific Statement From the American Heart Association © 2016 American Heart Association, Inc. Key Words: AHA Scientific Statements ? cardiovascular diseases ? comorbidity ? diabetes mellitus ? heart

Full Text available with Trip Pro

2016 American Heart Association

3. Athletic Heart Syndrome

Athletic Heart Syndrome Athletic Heart Syndrome Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Athletic Heart Syndrome Athletic Heart (...) Syndrome Aka: Athletic Heart Syndrome II. Physiology Normal reversible adaptations of heart to III. Signs Increased Left Ventricular wall thickness by 15-20% Increased Left Ventricular End Diastolic Volume by 10% Resting : 40-60 bpm Irregular pulse Increased S3 Gallup at Apex (S4 Gallup should raise red flag) Physiologic split S2 IV. Radiology May show globular cardiomegaly Increased pulmonary vasculature : Left Ventricular Dilatation (dynamic) Left Ventricular wall thickening (static) Normal Systolic

2018 FP Notebook

4. Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association

Athletes With Cardiovascular Abnormalities” apply to girls and women with TS who have valvular, congenital heart, or aortic disease. , Given the propensity for obesity and the metabolic syndrome in TS, healthcare professionals should be mindful of the significant benefits of having a heart-healthy lifestyle in light of the low risk of AoD in absolute terms (≈40:100 000 patient-years ) in this population. Therefore, consideration of the risk for AoD should be tempered by the importance of encouraging (...) Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine Search Hello Guest! Login to your account Email Password Keep me logged in Search February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free

Full Text available with Trip Pro

2018 American Heart Association

5. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease

fibrillation, who must receive anticoagulation therapy, should not engage in any competitive sports involving the risk of bodily contact (Class III; Level of Evidence C) . Mitral Regurgitation Mitral regurgitation (MR) has a variety of possible causes, the most common of which in an athletic population is mitral valve prolapse (myxomatous mitral valve disease). Other common causes are rheumatic heart disease, infective endocarditis, and connective tissue diseases (such as Marfan syndrome). Secondary forms (...) on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 7: aortic diseases, including Marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology. Circulation . 2015 ; 132 :e303–e309. doi: 10.1161/CIR.0000000000000243. Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, Eidem B, Edwards

Full Text available with Trip Pro

2015 American Heart Association

6. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February (...) 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease A Scientific Statement From the American Heart Association and American College of Cardiology , MD, FACC, Chair , MD, PhD, FACC

2015 American Heart Association

7. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome

February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome A Scientific Statement From the American Heart Association and American College (...) , and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 7: aortic diseases, including Marfan syndrome: a scientific statement from the American Heart Association and American College of Cardiology. Circulation . 2015;132:e303–e309. This article has been copublished in the Journal of the American College of Cardiology. Copies: This document is available on the World Wide Web sites of the American Heart

Full Text available with Trip Pro

2015 American Heart Association

8. Thoughts on a 23-year-old athlete dying from the Lemierre Syndrome

Thoughts on a 23-year-old athlete dying from the Lemierre Syndrome db's Medical Rants » Blog Archive » Thoughts on a 23-year-old athlete dying from the Lemierre Syndrome Internal medicine, American health care, and especially medical education 2 Posted by rcentor | Posted on 03-11-2018 Category : Every time I read such a story my heart breaks, a small piece each time. More physicians have become aware of the Lemierre syndrome. We must also educate patients and families that sore throats (...) in adolescents and young adults can become life threatening. Why did she die? The article does not have enough detail to develop a firm conclusion. I can speculate on several reasons from multiple discussions with both survivors and families of adolescents who died. We also have some unpublished survey data that informs my speculations. What do we know? Fusobacterium necrophorum is the predominant bacteria leading to the syndrome. Dr. Lemierre, in his classic description of the syndrome that now bears his

2018 db's Medical Rants blog

9. [The application of bioresonance therapy for the correction of the overtrained athlete syndrome]. (PubMed)

[The application of bioresonance therapy for the correction of the overtrained athlete syndrome]. Physical overload results in the development of pathological changes in the organs and systems and thereby causes their dysfunction. This leads to disadaptation, vegetative imbalance, and disturbances in the cardiovascular, nervous, endocrine and other systems. Taken together, these changes give rise to a syndrome of overtraining. In this context, the pathogenetically sound method of therapy (...) with the overtraining syndrome. They were divided into two groups each comprised of 30 subjects of comparable age, sex, sport, and sports qualification. Group I was composed of 30 athletes who were treated by means of bioresonance therapy. Group II (control) contained the athletes who received placebo procedures (i.e. the procedures with the use of a non-functioning device). All the athletes were examined before and after the treatment with the application of the clinical and instrumental methods.The study has

2018 Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury

10. Exercising recommendations for paroxysmal AF in young and middle-aged athletes (PAFIYAMA) syndrome (PubMed)

Exercising recommendations for paroxysmal AF in young and middle-aged athletes (PAFIYAMA) syndrome 28164109 2018 11 13 2305-5839 5 1 2017 Jan Annals of translational medicine Ann Transl Med Exercising recommendations for paroxysmal AF in young and middle-aged athletes (PAFIYAMA) syndrome. 24 10.21037/atm.2017.01.02 Perez-Quilis Carme C Department of Physiology, Faculty of Medicine, University of Valencia and Fundación Investigación Hospital Clínico Universitario de Valencia, Instituto de (...) ;; Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY, USA. eng Journal Article China Ann Transl Med 101617978 2305-5839 The authors have no conflicts of interest to declare. 2017 2 7 6 0 2017 2 7 6 0 2017 2 7 6 1 ppublish 28164109 10.21037/atm.2017.01.02 atm-05-01-24 PMC5253281 Circulation. 2016 Feb 2;133(5):457-9 26733608 Eur Heart J. 2013 Dec;34(47):3624-31 23756332 Eur Heart J. 2008 Jan;29(1):71-8 18065754 BMJ. 1998 Jun 13;316(7147):1784-5 9624065 Eur J

Full Text available with Trip Pro

2017 Annals of Translational Medicine

11. Left Atrial Enlargement in Young High-Level Endurance Athletes – Another Sign of Athlete’s Heart? (PubMed)

Left Atrial Enlargement in Young High-Level Endurance Athletes – Another Sign of Athlete’s Heart? Enlargement of the left atrium is perceived as a part of athlete's heart syndrome, despite the lack of evidence. So far, left atrial size has not been assessed in the context of exercise capacity. The hypothesis of the present study was that LA enlargement in athletes was physiological and fitness-related condition. In addition, we tried to assess the feasibility and normal values of left (...) atrial strain parameters and their relationship with other signs of athlete's heart. The study group consisted of 114 international-level rowers (17.5 ± 1.5 years old; 46.5% women). All participants underwent a cardio-pulmonary exercise test and resting transthoracic echocardiography. Beside standard echocardiographic measurements, two dimensional speckle tracking echocardiography was used to assess average peak atrial longitudinal strain, peak atrial contraction strain and early left atrial

Full Text available with Trip Pro

2016 Journal of human kinetics

12. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

indicates acute respiratory distress syndrome; ARVC, arrhythmogenic right ventricular cardiomyopathy; LH, left-sided heart disease; LVAD, left ventricular assist device; PAH, pulmonary arterial hypertension; PE, pulmonary embolism; PH, pulmonary hypertension; PR, pulmonary regurgitation; PS, pulmonary stenosis; RHF, right-sided heart failure; RV, right ventricular; RVMI, right ventricular myocardial infarction; TGA, transposition of the great arteries; and TR, tricuspid regurgitation. RVD is also (...) to the end of the QRS complex in V 1 . Reproduced with permission from Marcus et al. Copyright © 2010, American Heart Association. B , ECG with right ventricular hypertrophy. ECG demonstrating the changes of right ventricular hypertrophy. Long arrow indicates dominant R wave in V 1 ; short arrow , right-axis deviation; black arrowhead , right atrial abnormality; and open arrowhead , secondary ST-T changes. ARVC is more often associated with arrhythmia than isolated RVD. In Italy, where young athletes

Full Text available with Trip Pro

2018 American Heart Association

13. Atrial fibrillation in highly trained endurance athletes - Description of a syndrome. (PubMed)

Atrial fibrillation in highly trained endurance athletes - Description of a syndrome. Atrial fibrillation (AF) is the most common heart arrhythmia, the risk of which typically increases with age. This condition is commonly associated with major cardiovascular diseases and structural heart damage, while it is rarely observed in healthy young people. However, increasing evidence indicates that paroxysmal AF can also onset in young or middle-aged and otherwise healthy endurance athletes (e.g (...) ., cyclists, runners and cross-country skiers). Here we review the topic of AF associated with strenuous endurance exercise (SEE), for example cycling, running and cross-country skiing, especially at a competitive level, and we propose the definition of a new syndrome based on the accumulating data in the literature: SEE-related AF under the acronym of 'PAFIYAMA' ('paroxysmal AF in young and middle-aged athletes'). Special emphasis is given to the proper differentiation of PAFIYAMA from 'classical AF

2016 International journal of cardiology

14. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

Heart Disease: Recommendations e41 10.3. Geriatric Patients: Recommendations e41 10.4. Driving and Syncope: Recommendation e41 10.5. Athletes: Recommendations e41 11. Quality of Life and Healthcare Cost of Syncope e42 11.1. Impact of Syncope on Quality of Life e42 11.2. Healthcare Costs Associated with Syncope e42 12. Emerging Technology, Evidence Gaps, and Future Directions e42 12.1. Definition, Classification, and Epidemiology e42 12.2. Risk Stratification and Clinical Outcomes e43 12.3 (...) , and indexed in MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline, was conducted from July to October 2015. Key search words included but were not limited to the following: athletes, autonomic neuropathy, bradycardia, carotid sinus hypersensitivity, carotid sinus syndrome, children, death, dehydration, diagnosis, driving, electrocardiogram, electrophysiological study, epidemiology, falls

2017 American Heart Association

15. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association

. . . . . . . . . . . . . . . . . e295 11. Metabolic Syndrome . . . . . . . . . . . . . . . e313 12. Chronic Kidney Disease . . . . . . . . . . . . . e336 Cardiovascular Conditions/Diseases 13. Total Cardiovascular Diseases . . . . . . . . . . e349 14. Stroke (Cerebrovascular Disease). . . . . . . . . e374 15. Global CVD and Stroke . . . . . . . . . . . . . . e414 16. Congenital Cardiovascular Defects and Kawasaki Disease . . . . . . . . . . . . . . . . e423 17. Disorders of Heart Rhythm . . . . . . . . . . . . e440 18. Sudden (...) Cardiac Arrest . . . . . . . . . . . . . . e468 19. Subclinical Atherosclerosis . . . . . . . . . . . . e487 20. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris. . . . . . . . . . e505 21. Cardiomyopathy and Heart Failure . . . . . . . . e523 22. Valvular Diseases . . . . . . . . . . . . . . . . e539 23. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension. . . e548 24. Peripheral Artery Disease and Aortic

Full Text available with Trip Pro

2017 American Heart Association

16. An athletic 30-something woman with acute substernal chest pressure (PubMed)

dissection, or hemodynamic instability 6 . It is of extreme importance to suspect SCAD in this population (specifically women) in order to deliver the adequate management (avoid management as atherosclerotic ACS, unnecessary invasive strategy) and decrease the rate of complication. 1. Nishiguchi T, Tanaka A, Ozaki Y, Taruya A, Fukuda S, Taguchi H, Iwaguro T, Ueno S, Okumoto Y, Akasaka T. Prevalence of spontaneous coronary ar- tery dissection in patients with acute coronary syndrome. Eur Heart J Acute (...) An athletic 30-something woman with acute substernal chest pressure Dr. Smith's ECG Blog: An athletic 30-something woman with acute substernal chest pressure Tuesday, July 31, 2018 Post by Smith, with short article by Angie Lobo ( ), a third year intermal medicine resident at Abbott Northwestern Hospital Case A 30-something woman with no past history, who is very fit and athletic, presented with 1.5 hours of substernal chest pressure. It was non-radiating and without other associated symptoms

Full Text available with Trip Pro

2018 Dr Smith's ECG Blog

17. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

with prolonged QTc, drugs that prolong the QTc should be avoided. If they are deemed necessary, ECG should be performed 1–2 weeks after initiation of QT-prolonging drugs (⨁◯◯◯). R 4.16. We recommend that the function of the aortic valve and the presence of any other congenital heart disease and/or hypertension should be considered in determining participation recommendations for the athlete with TS and aortic dilation (⨁◯◯◯). R 4.17. We suggest that, for girls and women with TS ≥16 years with a moderately (...) years of age together with short stature a Typically bicuspid aortic valve, coarctation, aortic stenosis (with/without bicuspid aortic valve), mitral valve anomalies, and hypoplastic left heart syndrome. b Down-slanted palpebral fissures, epicanthal folds, low-set anomalous pinnae, micrognathia, narrow palate, short broad neck, and webbing. c Partial anomalous pulmonary venous return; atrial septal defect, secundum type; and ventricular septal defects, muscular or membranous. Turner syndrome

Full Text available with Trip Pro

2016 European Society of Human Reproduction and Embryology

18. Heart Disease and Stroke Statistics

. Physical Inactivity e99 5. Nutrition e119 6. Overweight and Obesity e138 Health Factors and Other Risk Factors 7. High Blood Cholesterol and Other Lipids e161 8. High Blood Pressure e174 9. Diabetes Mellitus e193 10. Metabolic Syndrome e212 11. Kidney Disease e233 12. Sleep e249 Cardiovascular Conditions/Diseases 13. Total Cardiovascular Diseases e257 14. Stroke (Cerebrovascular Disease) e281 15. Congenital Cardiovascular Defects and Kawasaki Disease e327 16. Disorders of Heart Rhythm e346 17. Sudden (...) Cardiac Arrest, Ventricular Arrhythmias, and Inherited Channelopathies e377 18. Subclinical Atherosclerosis e401 19. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris e415 20. Cardiomyopathy and Heart Failure e438 21. Valvular Diseases e455 22. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension e472 23. Peripheral Artery Disease and Aortic Diseases e481 Outcomes 24. Quality of Care e497 25. Medical Procedures

Full Text available with Trip Pro

2019 American Heart Association

19. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association | Arteriosclerosis, Thrombosis, and Vascular Biology Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article (...) are typically bilateral and symmetrical and always confined to skeletal muscle. , Cardiomyopathy has never been associated with any statin, and in the 2 major trials of statin therapy in participants with heart failure, statins did not lead to symptomatic worsening of the condition or any increase in hospitalization. , The excess risk of myopathy relative to placebo is <0.1% in large long-term RCTs with all currently marketed statins at up to maximum recommended doses. The risk is greatest in the first year

Full Text available with Trip Pro

2019 American Gastroenterological Association Institute

20. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease

ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease APPROPRIATE USE CRITERIA ACC/AATS/AHA/ASE/ASNC/ HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association (...) for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography,SocietyforCardiovascularMagneticResonance,andtheSocietyofThoracicSurgeons Writing Group Members John U. Doherty, MD, FACC, FAHA, Chair* Smadar Kort, MD, FACC, FASE, FAHAy Roxana Mehran, MD, FACC, FSCAI, FAHAz Paul Schoenhagen, MD, FAHAx Prem Soman, MD, PHD

2019 Heart Rhythm Society

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>